Mayo Clinic is partnering with a California-based firm to recruit 100,000 patients to participate in genetic testing to discover possible health problems and help develop a research database. Working ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia®, Inc. (OTC:BCDA) today announced publication of a study in the International Heart Journal. 1 According to the study, delivery of stem cell therapy to ...
In December 2020, San Francisco-based population genomics firm Helix received the first FDA approval for a whole-exome sequencing platform. The Helix Laboratory Platform offers coverage of ...
Partnership Will Examine Up to 10,000 Individuals Who Have Had Breakthrough Infections and Severe COVID Outcomes, Despite Full Vaccination SAN MATEO, Calif., Jan. 4, 2023 /PRNewswire/ -- Helix, the ...
BioCardia, Inc. today announced publication of a study in the International Heart Journal. According to the study, delivery of stem cell therapy to the heart using the Helix transendocardial delivery ...
One of the largest healthcare systems in the U.S. and a company involved in genomics plan to launch a study to collect population-level genetic data. San Mateo, California-based Helix said Thursday ...
TORONTO, ON--(Marketwired - Nov 30, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and ...
Helix BioPharma Corp., a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, has announced that it has filed a clinical trial application with the Central ...
ROCHESTER, Minn. — Mayo Clinic is partnering with a California-based firm to recruit 100,000 patients to participate in genetic testing to discover possible health problems and help develop a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback